Year archive

China NT Pharma Group Company Limited — 2016 filings

All 42 regulatory filings released by China NT Pharma Group Company Limited (1011) in 2016, sourced directly from the official regulator.

42 Filings

2016 Period

2016 filings (42)

Filing	Released	Lang
VOLUNTARY ANNOUNCEMENT NT PHARMA SUCCESSFULLY MAKES PAYMENT OF ACQUISITION ON MIACALCIC INJECTABLE AND SATISFACTORY PROGRESS OF MIACALCIC INJECTABLE ASSET TRANSFER Capital/Financing Update	2016-12-19	English
VOLUNTARY ANNOUNCEMENT UNUSUAL PRICE MOVEMENT AND INTENTION TO CONDUCT ON-MARKET SHARE REPURCHASE Transaction in Own Shares	2016-12-14	English
Monthly Return of Equity Issuer on Movements in Securities For the month ended 30 November 2016 Regulatory Filings	2016-12-05	English
Monthly Return of Equity Issuer on Movements in Securities For the month ended 31 October 2016 Regulatory Filings	2016-11-03	English
Next Day Disclosure Return Transaction in Own Shares	2016-10-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2016 Share Issue/Capital Change	2016-10-05	English
Interim Report 2016 Interim / Quarterly Report H1 2016	2016-09-23	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2016 Regulatory Filings	2016-09-02	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2016 Interim / Quarterly Report H1 2016	2016-08-18	English
NOTICE OF BOARD MEETING Regulatory Filings	2016-08-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2016 Capital/Financing Update	2016-08-01	English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 7 JULY 2016 Declaration of Voting Results & Voting Rights Announcements	2016-07-07	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2016 Regulatory Filings	2016-07-04	English
FORM OF PROXY FOR USE AT EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2016-06-21	English
NOTICE OF EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2016-06-21	English
MAJOR TRANSACTION BETWEEN THE COMPANY AND NOVARTIS IN RELATION TO THE ACQUISITION OF MIACALCIC INJECTABLE AND MIACALCIC SPRAY IN CHINA AND IN OTHER TERRITORIES AND NOTICE OF EXTRAORDINARY GENERAL Proxy Solicitation & Information Statement	2016-06-21	English
DELAY IN DESPATCH OF CIRCULAR Regulatory Filings	2016-06-13	English
VOLUNTARY ANNOUNCEMENT SONGZHI WAN OFFICIALLY LAUNCHED INTO THE MARKET Regulatory Filings	2016-06-08	English
Monthly Return of Equity Issuer on Movements in Securities For the month ended 31 May 2016 Regulatory Filings	2016-06-01	English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION Board/Management Information	2016-05-31	English
APPOINTMENT OF NON-EXECUTIVE DIRECTOR Board/Management Information	2016-05-31	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 19 MAY 2016 Declaration of Voting Results & Voting Rights Announcements	2016-05-19	English
EXCHANGE NOTICE - RESUMPTION OF TRADING Regulatory Filings	2016-05-19	English
ANNOUNCEMENT PURSUANT TO RULE 13.18 OF THE LISTING RULES Capital/Financing Update	2016-05-18	English
MAJOR TRANSACTION BETWEEN THE COMPANY AND NOVARTIS IN RELATION TO THE ACQUISITION OF MIACALCIC INJECTABLE AND MIACALCIC SPRAY IN CHINA AND IN OTHER TERRITORIES AND RESUMPTION OF TRADING M&A Activity	2016-05-18	English
TRADING HALT Regulatory Filings	2016-05-18	English
EXCHANGE NOTICE - TRADING HALT Regulatory Filings	2016-05-18	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2016 Share Issue/Capital Change	2016-05-03	English
STRATEGIC COOPERATION FRAMEWORK AGREEMENT Regulatory Filings	2016-04-28	English
NOTICE OF ANNUAL GENERAL MEETING AGM Information	2016-04-19	English
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING AGM Information	2016-04-19	English
PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES AND PROPOSED RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING AGM Information	2016-04-19	English
Annual Report 2015 Annual Report FY 2015	2016-04-19	English
VOLUNTARY ANNOUNCEMENT POTENTIAL ACQUISITION M&A Activity	2016-04-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2016 Regulatory Filings	2016-04-01	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2015 Annual Report FY 2015	2016-03-23	English
NOTICE OF BOARD MEETING Regulatory Filings	2016-03-08	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2016 Capital/Financing Update	2016-03-02	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2016 Capital/Financing Update	2016-02-01	English
POSITIVE PROFIT ALERT Earnings Release FY 2015	2016-01-29	English
VOLUNTARY ANNOUNCEMENT - NT Pharma will Commence Clinical Research of Lurasidone Hydrochloride The Antipsychotic Drug Demonstrates Significant Advantages and Great Market Potential Regulatory Filings	2016-01-26	English
Monthly Return of Equity Issuer on Movements in Securities For the month ended 31 December 2015 Share Issue/Capital Change	2016-01-05	English

Filings by year

2026 31 filings
2025 67 filings
2024 53 filings
2023 41 filings
2022 46 filings
2021 31 filings
2020 54 filings
2019 61 filings
2018 46 filings
2017 47 filings
2016 42 filings
2015 53 filings
2014 39 filings
2013 37 filings
2012 45 filings
2011 25 filings